Effectiveness and occurence of adverse events of Medical Flossing in patients with shoulder disorders - a randomized controlled pilot trial

Phase 2

• Conditions: M75.0; M75.1; Calcific tendinitis of shoulder; M75.3; M75.4; M75.8; M75.9; M79.61; M19.11; Shoulder lesion, unspecified

• Registration Number: DRKS00012747
• Lead Sponsor: Hochschule für Gesundheit Department für GesundheitswissenschaftenStudiengang Physiotherapie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-12-31
• Study Start: 2018-01-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Shoulder pain and/or loss of range of motion, fluent German language

Exclusion Criteria

• Tumors / metastases in the shoulder area
• lymphedema around the shoulder
• Inflammation marks around the shoulder
• Thrombosis Vascular diseases in the arm (e.g., PAOD, varices)
• decompensated heart failure (NYHA III, NYHA IV)
• Taking anticoagulants
• Taking cortisone
• Pregnancy
• skin diseases in the area of the shoulder (for example atopic dermatitis, psoriasis)
• Skin damage / wounds around the shoulder
• Nerve lesion around the shoulder / armpit
• Condition after shoulder luxation within the last 6 weeks
• Condition after shoulder surgery within the last 4 weeks without release of stress or movement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disabilities of the Arm, Shoulder and Hand (DASH) at inclusion, before third treatment session and after the last treatment session

Secondary Outcome Measures

Name	Time	Method
Pain (NRS), Range of motion (Goniometer), patient-reported overall treatment effect and adverse events using a self developed questionnaire. Time of data aquisition: at inclusion, before third treatment session and after the last treatment session.